Anaerobic membrane bioreactors (AnMBR) are currently in the early adopter section of the technology adoption S-curve, but with companies like GE and Aquabio entering this space, BlueTech expect the technology to move into the early majority section of the technology adoption stages in the next five years.

This is a preview only.

Only BlueTech® Research Clients have full access.

The Intelligence Briefings are available to clients.

Learn About Membership